Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling

J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e152-e155. doi: 10.1111/jdv.16883. Epub 2020 Sep 25.

Authors

K Süßmuth¹, H Traupe¹, K Loser², S Ständer^{1

3}, C Kessel⁴, H Wittkowski⁴, V Oji^{1

5}

Affiliations

¹ Department of Dermatology, University Hospital Münster, Münster, Germany.
² Institute of Immunology, University of Oldenburg, Oldenburg, Germany.
³ Center for Chronic Pruritus, University Hospital Münster, Münster, Germany.
⁴ Department of Pediatric Rheumatology and Immunology, University Children's Hospital Münster, Münster, Germany.
⁵ Hautarztpraxis am Buddenturm, Münster, Germany.

PMID: 32810299
DOI: 10.1111/jdv.16883

No abstract available

Keywords: atopic dermatitis; genetics; genodermatoses; ichthyoses; immunology.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Child
Humans
Interleukin-13
Netherton Syndrome* / complications
Netherton Syndrome* / drug therapy
Netherton Syndrome* / genetics
Pruritus / drug therapy

Substances

Antibodies, Monoclonal, Humanized
Interleukin-13
dupilumab